BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Harvard Business School
QuintilesIMS
Queensland Health
Teva
Julphar
Cipla
Boehringer Ingelheim
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

VISTARIL Drug Profile

« Back to Dashboard

When do Vistaril patents expire, and when can generic versions of Vistaril launch?

Vistaril is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in VISTARIL is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.

US Patents and Regulatory Information for VISTARIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer VISTARIL hydroxyzine hydrochloride INJECTABLE;INJECTION 011111-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459-004 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer VISTARIL hydroxyzine pamoate SUSPENSION;ORAL 011795-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer VISTARIL hydroxyzine hydrochloride INJECTABLE;INJECTION 011111-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Boehringer Ingelheim
Julphar
AstraZeneca
US Army
Mallinckrodt
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot